Medical Tech Company Agrees to $3.6 Million Settlement of Self-Disclosed False Claims
- March 05, 2021
Global medical technology company Bioventus, LLC, has agreed to pay the government $3,609,087 to resolve allegations that it violated the False Claims Act by submitting improperly completed certificates of medical necessity (CMN) for medically unnecessary devices, U.S. Attorney for the Middle District of North Carolina Matthew G. T. Martin announced February 25.
ARTICLE TAGS
You must be logged in to access this content.